Background: With improved survival in children living with human immunodeficiency virus (HIV) infection (CLHIV), malignancies are being increasingly recognized. Patients and methods: Among the CLHIV registered at our institute from January 1994 to March 2015, children with malignancy were analysed in detail. Results: In total, 734 children affected by HIV were registered. Out of these, 11 children (9 boys, 2 girls) were diagnosed to have malignancy. Malignancy was the presenting feature of HIV infection in 4 children. High-grade non-Hodgkin lymphoma (NHL) was the most common malignancy noted in 9 of 11 (81%) children, whereas the remaining 2 children had Hodgkin's lymphoma. Survival in our cohort was 80% among children in whom chemotherapy was initiated, and overall survival was 36% (4 of 11 children). Conclusion: NHL was the most common malignancy in CLHIV in our cohort. Low-conditioning chemotherapy protocols along with initiation of anti-retroviral therapy resulted in improved outcomes in CLHIV with malignancy.
I N T R O D U C T I O N
With effective, accessible and affordable antiretroviral therapy (ART), human immunodeficiency virus (HIV) infection in children is no longer a fatal disease but is recognized to be a chronic manageable condition. As more and more children living with HIV (CLHIV) are surviving to adulthood, malignancies are being increasingly recognized. Total number of CLHIV in India was estimated to be around 138 000 in 2015, yet data regarding malignancies and outcomes are extremely limited [1] .
P A T I E N T S A N D M E T H O D S
Case records of all children diagnosed to have HIV infection at our centre from January 1994 to March 2015 were reviewed. Diagnosis of HIV infection in children above 18 months was confirmed by enzyme-linked immunosorbent assay [2] . Children who were diagnosed as having malignancy at presentation or at follow-up were analysed in detail. Chemotherapy was administered in collaboration with the Paediatric Haemato-Oncology (PHO) unit.
R E S U L T S
In total, 734 perinatally infected CLHIV were registered. Out of these, 11 children (9 boys and 2 girls) were diagnosed to have malignancy. Mean age at diagnosis of HIV infection was 6.3 6 3.5 years (1.5-13 years) and that at diagnosis of malignancy was 9.6 6 2.5 years (7-13 years). Malignancy was the presenting feature of HIV infection in 4 cases. Three CLHIV were under regular follow-up with preserved CD4 counts but later developed malignancy. Four children had received ART for a mean duration of 3.9 years (1 month-6.5 years) before malignancy was diagnosed. Salient clinical features have been tabulated (Table 1) .
High-grade non-Hodgkin lymphoma (NHL) was noted in 9 of 11 (81%) children, whereas the remaining 2 children had Hodgkin's lymphoma (HL). Extra-nodal disease was noted in all patients. Both children diagnosed to have HL had Stage IV disease (Ann Arbor staging). Severe immunosuppression (CD4 counts below 15% of total lymphocyte count) was seen in 7 children, whereas 3 of them had an absolute number <100/mm 3 . Trend of absolute CD4 counts in CLHIV has been depicted in Fig. 1 .
Epstein-Barr virus (EBV) infection (IgM antibodies)
was documented in 1 of 10 children. Screenings for hepatitis B and C infections were negative in all.
Chemotherapy was initiated in 5 of 11 children. Two patients (Patients 4 and 7) died before chemotherapy could be initiated, and the parents/caregivers of four children opted against therapy owing to financial constraints. Low-intensity modified chemotherapy protocols were used (Table 1) . ART-naive patients were simultaneously started on ART as per national guidelines [3] . Four children completed chemotherapy and are doing well on regular ART, whereas Patient 6 succumbed to illness during the second phase of chemotherapy.
Survival in our cohort was 80% among children in whom chemotherapy was initiated, and overall survival was36% (4 of 11 children). Total duration of disease-free survival was 9.2 patient-years (1 to 4 patient-years).
D I S C U S S I O N
Children with HIV are at a 10-fold higher risk of developing malignancy compared with HIV-negative children [4] . Incidence of HIV-associated malignancy in our cohort was found to be 1.49%, whereas a multi-centric study from the USA reported an incidence of 2.5% [5] . Similar studies have been tabulated (Table 2) . NHL has been the most frequently reported malignancy in the Indian population [10] . In our cohort, NHL was the predominant malignancy noted in 81% of CLHIV.
Early recognition of malignancy in CLHIV is a diagnostic challenge owing to overlapping clinical features [11] . This may result in delay in diagnosis, and hence, HIV infection is often recognized in advanced stages [12] . We also found extra-nodal disease in all children at the time of diagnosis, and this contributed to poorer prognosis.
Although malignancy as the first presenting manifestation of HIV infection has been reported among adults [13, 14] , this is distinctly uncommon in children. Four children presented with malignancy and associated HIV infection was diagnosed later. HIV infection in children is likely to progress much faster compared with adults, and hence, latent infections are uncommon. We speculate that these children could represent long-term survivors, as they remained clinically asymptomatic for a long time. Patient 1 presented for the first time with rightsided orbital and cheek swelling (Fig. 2) and was diagnosed to have NHL. Screening for HIV infection in this child was prompted by the history of unexplained death of his mother at young age and highrisk behaviour in father. Patient 3, diagnosed with Burkitt's lymphoma (BL), had presented with sudden onset of paraplegia. Magnetic resonance imaging (MRI) of the spine revealed paravertebral mass compressing the thoracic cord (Fig. 3) . A similar case has been reported in an HIV-positive adult [15] from our institute but never in children. Patient 5 developed ART failure after 7 years of therapy and was started on second-line ART. During the clinical course, she developed oedema and nephrotic-range proteinuria. Renal biopsy was normal. Aspiration cytology of enlarged mediastinal nodes yielded the diagnosis of NHL. In patients with lymphomas, renal pathology often resembles minimal change disease (MCD) [16] , which is due to lymphokines that increase glomerular capillary wall permeability. Our index child also had MCD secondary to NHL, and this kind of presentation is extremely rare in the paediatric age group. Patient 8, who was diagnosed as having BL involving the jaw, had also suffered from reactive arthritis of the left knee joint in the past. He was HLA B27-positive. While HLA B27 is known to provide some protection against HIV [17] , immune activation with repeated infections may have caused cancer in the index child.
Two children (Patients 6 and 8) in pre-ART care with CD4 counts more than 15% were noted to develop malignancy after 0.5 years and 2 years of follow-up, respectively. Thus, CLHIV with long-standing latent infection and preserved CD4 counts may still develop malignancies [18] . Co-infection with EBV is implicated in 40% of HIV-associated malignancy cases. Routine screening of all CLHIV for EBV is not feasible even in tertiary care centres in India. EBV IgM antibodies were elevated in 1 of 10 cases. EBV polymerase chain reaction was not performed owing to financial constraints.
Outcome of children with HIV and malignancy has been poor compared with children without HIV. Immune recovery occurs in interval phases during cyclical courses of chemotherapy in HIV-negative children; however, in children with HIV infection, there is progressive decline in immunity as a result of viral replication. Thus, children succumb to serious infections while on chemotherapy. This has been reflected in some of the early studies wherein intensive chemotherapy protocols were used in absence of ART, and this resulted in high mortality [8, 19, 20] . Hence, CLHIV with malignancy are managed with less-aggressive chemotherapeutic protocols [21] . In our study, low-conditioning ABVD regimen was used in HL, and the GRAB protocol [22] was used in children with BL. All of them received ART simultaneously.
To conclude, HIV-associated malignancies are being increasingly recognized in children with improved survival of CLHIV. The clinical presentations are varied and high index of suspicion is needed on part of the treating physicians to diagnose these conditions early. NHL was the most common malignancy in CLHIV in our cohort. Malignancy was identified at the first presentation of HIV infection in 4 of 11 children with cancer. Low-conditioning chemotherapy protocols along with initiation of ART resulted in good outcomes.
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